pharmaphorum
NOVEMBER 23, 2020
The new, free of charge section makes tailored information about wet AMD available to the approximately 20 million people worldwide with wet AMD along with tools to help them stay on track with treatment and in communication with their doctors. The post Novartis taps smartpatient for app to support wet AMD patients appeared first on.
pharmaphorum
JANUARY 5, 2023
Recruiting and retaining talent is one of the biggest challenges facing the industry now through 2028, as the US Bureau of Labor Statistics expects life, physical, and social sciences to grow 7%. Investing in technology for onboarding, training, and employee communication can help cut expenses and positively impact engagement.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
AUGUST 15, 2022
According to GAVI – the Vaccine Alliance, the drug maker had already agreed to cut its deliveries of rotavirus vaccine by 10 million a year between 2022 and 2028. Reuters reported that GSK had acknowledged the fall in supply and said it was pursuing plans to address the deficit.
European Pharmaceutical Review
MARCH 9, 2023
Based on the latest report and data, HPAPI market size is expected to reach $32 billion by 2028. The compounds require special handling due to their cytotoxicity in the NCEs and investigational new drug applications (INDs). 1 What are the challenges companies face in identifying and assessing the toxicity and potency of HPAPIs?
pharmaphorum
OCTOBER 10, 2022
In 2021, a pilot communications programme from AstraZeneca UK and the NHS was launched in four locations across England. The goal set out by the NHSE Long Term Plan is ambitions: to have three quarters of cancers diagnosed at an early stage by 2028. It exists in multiple areas across multiple organisations.
The Checkup by Singlecare
DECEMBER 12, 2024
Addyi is currently only available as a brand-name drug , but a generic Addyi may be available after 2028. Seek professional advice from a healthcare provider on other treatment options Financial constraints are difficult, and open communication with your healthcare provider is strongly encouraged if accessing Addyi is a problem.
Pharmaceutical Technology
JUNE 20, 2023
With two of its upcoming drug launches already pipped to be blockbusters by 2028, smart manoeuvres in the immunology space could help Lilly close the gap between itself and other companies like Johnson & Johnson. Please check your email to download the Report.
Expert insights. Personalized for you.
98 
Let's personalize your content